RECRUITING

CardioFocus HeartLight Post-Approval Study

Description

This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

Study Overview

Study Details

Study overview

This is a post-approval study to evaluate the clinical outcomes in a cohort of participants treated during commercial use of the HeartLight System to confirm results of the previously conducted pivotal clinical study.

Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation

CardioFocus HeartLight Post-Approval Study

Condition
Atrial Fibrillation
Intervention / Treatment

-

Contacts and Locations

Tucson

University of Arizona Sarver HeartCenter, Tucson, Arizona, United States, 85724

Chicago

University of Illinois, Chicago, Illinois, United States, 60612

New York

Mount Sinai Hospital, New York, New York, United States, 10029

Charlottesville

University Of Virginia Health System, Charlottesville, Virginia, United States, 22908

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years or older
  • * planned for catheter ablation due to symptomatic paroxysmal atrial fibrillation
  • * failure of at least one anti-arrhythmic drug
  • * others
  • * overall good health as established by multiple criteria

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

CardioFocus,

Study Record Dates

2028-10